212 related articles for article (PubMed ID: 31979093)
41. Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD.
Wu C; Zhao A; Tan T; Wang Y; Shen Z
Exp Ther Med; 2019 Jul; 18(1):550-558. PubMed ID: 31258693
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of SOX9 suppresses breast cancer cell proliferation and migration by regulating apoptosis and cell cycle arrest.
Wang YF; Dang HF; Luo X; Wang QQ; Gao C; Tian YX
Oncol Lett; 2021 Jul; 22(1):517. PubMed ID: 33986877
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of metadherin inhibits angiogenesis in breast cancer.
Liu Y; Kong X; Li X; Li B; Yang Q
Int J Oncol; 2015; 46(6):2459-66. PubMed ID: 25902416
[TBL] [Abstract][Full Text] [Related]
44. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
[TBL] [Abstract][Full Text] [Related]
45. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
46. Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines.
Enciso-Benavides J; Alfaro L; Castañeda-Altamirano C; Rojas N; González-Cabeza J; Enciso N; Riesco F; Castillo M; Enciso J
Heliyon; 2021 Jun; 7(6):e07273. PubMed ID: 34235281
[TBL] [Abstract][Full Text] [Related]
47. A Preliminary Study on Metadherin as a Potential Marker for Progression of Diffuse Large B Cell Lymphoma.
Ge X; Sui X; Fang X; Jiang Y; Ding M; Liu X; Wang X
Genet Test Mol Biomarkers; 2018 Aug; 22(8):481-486. PubMed ID: 30117777
[TBL] [Abstract][Full Text] [Related]
48. Metadherin: A Therapeutic Target in Multiple Cancers.
Dhiman G; Srivastava N; Goyal M; Rakha E; Lothion-Roy J; Mongan NP; Miftakhova RR; Khaiboullina SF; Rizvanov AA; Baranwal M
Front Oncol; 2019; 9():349. PubMed ID: 31131259
[TBL] [Abstract][Full Text] [Related]
49. Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer.
Chen S; Li Y; Wu M; Xue L; Zhu J; Wu M; Zhang Q; He G; Li G; Fu S; Zheng C; Deng X
Front Oncol; 2022; 12():731528. PubMed ID: 35174077
[TBL] [Abstract][Full Text] [Related]
50. Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression.
Sha S; Yuan D; Liu Y; Han B; Zhong N
Biol Open; 2017 Sep; 6(9):1310-1316. PubMed ID: 28760736
[TBL] [Abstract][Full Text] [Related]
51. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
[TBL] [Abstract][Full Text] [Related]
52. Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.
Chen C; Wang S; Liu P
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597263
[TBL] [Abstract][Full Text] [Related]
53. Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma.
Li PP; Feng LL; Chen N; Lu K; Meng XH; Ge XL; Lv X; Wang X
Int J Clin Exp Med; 2014; 7(8):2081-6. PubMed ID: 25232390
[TBL] [Abstract][Full Text] [Related]
54. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
[TBL] [Abstract][Full Text] [Related]
55. Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells.
Rosado-Galindo H; Domenech M
Front Cell Dev Biol; 2023; 11():1124250. PubMed ID: 36968199
[No Abstract] [Full Text] [Related]
56. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
Ren YQ; Fu F; Han J
Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633
[TBL] [Abstract][Full Text] [Related]
57. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
58. PEITC treatment suppresses myeloid derived tumor suppressor cells to inhibit breast tumor growth.
Gupta P; Wright SE; Srivastava SK
Oncoimmunology; 2015 Feb; 4(2):e981449. PubMed ID: 25949878
[TBL] [Abstract][Full Text] [Related]
59. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
[TBL] [Abstract][Full Text] [Related]
60. Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells
Wang K; Zhu X; Yin Y
Front Pharmacol; 2020; 11():835. PubMed ID: 32581798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
